🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 27% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Tablet(s) Serving Size
60 Servings
Other Combinations Product Type
27% Evidence Coverage

Supplement Facts — Evidence Check

Calories
3 Calorie(s)
Total Carbohydrates
1 Gram(s) (1% DV)
Total Sugars
1 Gram(s)
Added Sugars
1 Gram(s) (1% DV)
15 mg (4% DV)
📊 Market median: 4002.0mg (1 products) 📚 20 studies (Tier A: 0, B: 2)
This product: 15mg
Sodium
7 mg (1% DV)
Potassium
43 mg (1% DV)
Grapefruit Pectin
100 mg
Bismuth Subnitrate
50 mg
50 mg
📊 Market median: 60.0mg (94 products) 📚 13 studies (Tier A: 0, B: 7)
This product: 50mg
📊 Market median: 420.0mg (127 products) 📚 1 studies (Tier A: 0, B: 1)
This product: 10mg

Other Ingredients

Dextrose Magnesium Stearate Stearic Acid natural Peppermint flavor Xylitol Bitter Blocker BESTEVIA

Label Claims — Verification

All Other
Structure/Function
All Other (99% of products) Structure/Function (85% of products) Nutrient (54% of products) Approved Health (3% of products)

Target Groups

Adult (18 - 50 Years) Women (not pregnant or lactating)

Product Information

📋 Directions for Use

Recommendations: Take one (1) capsule daily or as directed by your physician.

⚠️ Warnings & Precautions

Warning: Contains licorice root. Do not use during pregnancy.

Keep out of reach of children.

Contains: soy (lecithin)

For professional use only.

🧪 Formulation Notes

Contains no preservatives.

Providing relief for occasional indigestion.

Additional Information

Keep container tightly closed, store in a cool, dry place.

Bisphenol-A (BPA) & Phthalate Free

GMP Certified

Product Details

UPC / SKU 8 15354 02162 1
DSLD Entry Date 2022-10-24
Product Type Other Combinations
Form Tablet or Pill
DSLD ID 277410
Data Updated 2026-04-11

Research Evidence

849 Research Sources
56 Avg Quality Score
450 Meta Analysis
152 Rct
137 Systematic Review
73 Clinical Trial
11 Regulatory Source
7 Other
7 Guideline
3 Openfda Safety
2 Cochrane Review
2 Observational
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023
A Dietary sodium, sodium-to-potassium ratio, and risk of stroke: A systematic review and nonlinear dose-response meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2019
A The association between circulating magnesium and clinically relevant outcomes in patients with chronic kidney disease: A systematic review and meta-analysis
Meta Analysis Clinical nutrition (Edinburgh, Scotland) 2021
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021
View all evidence for Electrolytes →

Compare Similar Products

View all Electrolytes products →